Similar Posts
Deep diving into bitcoin ETFs trading day
CNBC’s Kate Rooney and Bob Pisani join ‘Power Lunch’ to discuss bitcoin ETFs trading day.
Watch CNBC’s full interview with Piper Sandler’s Harsh Kumar
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Harsh Kumar, Piper Sandler senior research analyst, joins ‘TechCheck’ to discuss Kumar’s hesitations around Micron’s stock, what would lessen his concerns around Micron and whether the Chips Act is baked in to his rating on Micron. 06:23 Wed, Mar 30 202211:34 AM…
Bernstein’s Stacy Rasgon weighs in on semiconductor rally
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell: Overtime Stacy Rasgon, Bernstein Research chip analyst, joins ‘Closing Bell: Overtime’ to discuss semiconductor stocks. 04:32 Fri, Sep 9 20225:20 PM EDT
Options traders betting Nike’s post earnings move has some real sole
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fast Money Mike Khouw, Optimize Advisors president, joins CNBC’s Melissa Lee and the Options Action traders to talk Nike. 01:52 Wed, Sep 27 20236:10 PM EDT
Jim Cramer’s guide to investing: Pay attention to big insider buying
CNBC’s Jim Cramer said investors should usually wait until high-quality stocks have had a pullback before buying. But sometimes it’s worth buying some stock at the top, especially if a company engages in significant insider buying. Not to be confused with insider trading, insider buying is based on public information and occurs when executives buy…
Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
